Extracorporeal rheopheresis in the treatment of acute ischemic stroke: A randomized pilot study

Stroke

Volumn 30, Issue 4, 1999, Pages 787-792

  Berrouschot, Jörg ^a   Barthel, Henryk ^b   Köster, Johannes ^b   Hesse, Swen ^b   Rössler, Annegret ^b   Knapp, Wolfram H ^b   Schneider, Dietmar ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b NONE

Author keywords

Rheology; Stroke, ischemic; Tomography, emission computed; Viscosity

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD RHEOLOGY; BRAIN FUNCTION; BRAIN PERFUSION; BRAIN SCINTISCANNING; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROCYTE AGGREGATION; EXTRACORPOREAL CIRCULATION; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; PLASMA VISCOSITY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0032892983     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.4.787     Document Type: Article

References (49)

1. Berrouschot J, Barthel H, Scheel C, Köster J, Schneider D. Extracorporeal membrane differential filtration: a new and safe method to optimize hemorheology in acute ischemic stroke. Acta Neurol Scand. 1998;97: 126-130.
2. Holman BL, Hellman RS, Goldsmith SJ, Mena IG, Léveillé J, Gherardi PG, Moretti JL, Bischof DA, Hill TC, Rigo PM. Biodistribution, dosimetry, and clinical evaluation of technetium-99m ethyl cysteinate dimer in normal subjects and in patients with chronic cerebral infarction. J Nucl Med. 1989;30:1018-1024.
3. Léveillé J, Demonceau G, Walovitch RC. Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects. J Nucl Med. 1992;33:480-484.
4. 99mTc-ECD-SPECT. J Cereb Blood Flow Metab. 1998;18:921-929.
5. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne MH, Hennerici M. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
6. Larrue V, von Kummer R, del Zoppo G, Bluhmki E. Hemorrhagic transformation in acute ischemic stroke: potential contributing factors in the European Cooperative Acute Stroke Study. Stroke. 1997;28:957-960.
7. Talairach J, Tournoux P. Co-planar Stereotactic Atlas of the Human Brain. New York, NY: Thieme Verlag; 1988.
8. Podreka I, Suess E, Goldenberg G, Steiner M, Brucke T, Muller C, Lang W, Neirinckx RD, Deecke L. Initial experience with technetium-99m HMPAO brain SPECT. J Nucl Med. 1987;28:1657-1666.
9. Hanson SK, Grotta JC, Rhoades H, Tran HD, Lamki LM, Barron BJ, Taylor WJ. Value of single-photon emission-computed tomography in acute stroke therapeutic trials. Stroke. 1993;24:1322-1329.
10. Baird AE, Donnan GA, Austin MC, Fitt GJ, Davis SM, McKay WJ. Reperfusion after thrombolytic therapy in ischemic stroke measured by single-photon emission computed tomography. Stroke. 1994;25:79-85.
11. Yasaka M, O'Keefe GJ, Chambers BR, Davis SM, Infeld B, O'Malley H, Baird AE, Hirano T, Donnan GA. Streptokinase in acute stroke: effect on reperfusion and recanalization. Neurology. 1998;50:626-632.
12. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in acute ischemic stroke, I: results in the total patient population. Stroke. 1987;18:691-699.
13. The Hemodilution in Stroke Study Group. Hypervolemic hemodilution treatment of acute stroke: results of a randomized multicenter trial using pentastarch. Stroke. 1989;20:317-323.
14. Italian Acute Stroke Study Group. Hemodilution in acute stroke: results of the Italian hemodilution trial. Lancet. 1988;1:318-321.
15. Aichner FT, Fazekas F, Brainin M, Pölz W, Mamoli B, Zeiler K. Hypervolemic hemodilution in acute ischemic stroke: the Multicenter Austrian Hemodilution Stroke Trial (MAHST). Stroke. 1998;29:743-749.
16. Yanaka K, Camarata PJ, Spellman SR, Mc Donald DE, Heros RC. Optimal timing of hemodilution for brain protection in a canine model of focal cerebral ischemia. Stroke. 1996;27:906-912.
17. Goslinga H, Eijzenbach V, Heuvelmans JHA, van der Laan de Vries E, Melis VMJ, Schmid-Schönbein H, Bezemer PD. Custom-tailored hemodilution with albumin and crystalloids in acute ischémie stroke. Stroke. 1992;23:181-188.
18. Gaehtgens P, Marx P. Hemorheological aspects of the pathophysiology of cerebral ischemia. J Cereb Blood Flow Metab. 1987;7:259-265.
19. von Kummer R, Scharf, J, Back T, Reich H, Machens HG, Wildemann B. Autoregulatory capacity and the effect of isovolemic hemodilution on local cerebral blood flow. Stroke. 1988;19:594-597.
20. Thomas DJ, Du Boulay GH, Marshall J, Pearson TC, Ross Russel RW, Symon L, Wetherley-Mein G, Zilkha E. Effect of haematocrit on cerebral blood flow in man. Lancet. 1977;2:941-943.
21. Wade JPH. Transport of oxygen to the brain in subjects with elevated hematocrit before and after venesection. Brain. 1983;106:513-523.
22. Chan R, Leniger-Follert E. Effect of isovolemic hemodilution on oxygen supply and electrocorticogram in cat brain during focal ischemia and in normal tissue. Int J Microcirc Clin Exp. 1983;2:297-313.
23. Merril EW. Rheology of blood. Physiol Rev. 1969;49:863-887.
24. Pries AR, Secomb TW, Gaehtgens P, Gross JF. Blood flow in microvascular networks: experiments and simulations. Circ Res. 1990;67: 826-834.
25. Grotta JC. Rheology of flow and its effects. In: Caplan LR, ed. Brain Ischemia. London, England: Springer-Verlag; 1995:261-268.
26. Busnach G, Dal Col A, Brando B, Cappelleri A, Perrino ML, Brunati C, Minetti L. Different cascade filtration operating modalities in clinical use. Int J Artif Organs. 1988;11:493-496.
27. Seplowitz AH, Chien S, Smith FR. Effects of lipoproteins on plasma viscosity. Atherosclerosis. 1981;38:89-95.
28. Dintenfass L, Kammer S. Plasma viscosity in 615 subjects: effect of fibrinogen, globulin and cholesterol in normals, peripheral vascular disease, retinopathy and melanoma. Biorheology. 1977;14:247-251.
29. Rubba P, Faccenda F, Di Somma S, Gnasso A, Scarpato N, Iannuzzi A, Nappi G, Postiglione A, De Divitiis O, Mancini M. Cerebral blood flow velocity and systemic vascular resistance after acute reduction of low-density lipoprotein in familial hypercholesterolemia. Stroke. 1993;24: 1154-1161.
30. Reinhard WH. Boulanger CM, Lüdscher TF, Haeberli A, Straub PW. Influence of endothelial surface on flow velocity in vitro. Am J Physiol. 1993;265:523-529.
31. Walzl M, Lechner H, Walzl B, Schied G. Improved neurological recovery of cerebral infarctions after plasmapheretic reduction of lipids and fibrinogen. Stroke. 1993;24:1447-1451.
32. Herderscheê D, Limburg M, van Royen EA, Hijdra A, Büller HR, Koster PA. Thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: evaluation with rCBF-SPECT. Acta Neurol Scand. 1991; 83:317-322.
33. Overgaard K, Sperling B, Boysen G, Pedersen H, Gam J, Ellemann K, Karle A, Arlien-Söberg P, Olsen TS, Videbak C, Knudsen JB. Thrombolytic therapy in acute ischemic stroke: a Danish pilot study. Stroke. 1993;24:1439-1446.
34. Giubilei F, Lenzi GL, Di Piero V, Pozzilli C, Pantano P, Bastianello S, Argentino C, Fieschi C. Predictive value of brain perfusion single-photon emission computed tomography in acute ischemic stroke. Stroke. 1990; 21:895-900.
35. Grotta JC, Alexandrov AV. tPA-associated reperfusion after acute stroke demonstrated by SPECT. Stroke. 1998;29:429-432.
36. Alexandrov AV, Black SE, Ehrlich LE, Bladin CF, Smurawska LT, Pirisi A, Caldwell CB. Simple visual analysis of brain perfusion on HMPAO SPECT predicts early outcome in acute stroke. Stroke. 1996;27: 1537-1542.
37. 99mTc-bicisate in the localization and definition of mechanism of ischemic stroke. J Cereb Blood Flow Metab. 1994;14(suppl 1):S91-S98.
38. Ginsberg MD, Pulsinelli W. The ischemic penumbra, injury thresholds, and the therapeutic window for acute stroke. Ann Neurol. 1994;36:553-554.
39. Hossman KA. Viability thresholds in cerebral and the penumbra of focal ischemia. Ann Neurol. 1994;36:557-565.
40. Pulsinelli W. The therapeutic window in ischemic brain injury. Curr Opin Neurol. 1995;8:3-5.
41. Jones TH, Morawetz RB, Crowell RM, Marcoux FW, FitzGibbon SJ, DeGirolami U, Ojemann RG. Threshold of focal cerebral ischemia in awake monkeys. J Neurosurg. 1981;54:773-782.
42. Zivin JA. Factors determining the therapeutic window for stroke. Neurology. 1998;50:599-603.
43. Diener HC. Multinational randomised controlled trial of lubeluzole in acute ischaemic stroke. Cerebrovasc Dis. 1998;8:172-181.
44. The RANTTAS Investigators. A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS). Stroke. 1996;27:1453-1458.
45. Grotta JC. Lubeluzole treatment of acute ischemic stroke. Stroke. 1997; 28:2338-2346.
46. Multicenter Acute Stroke Trial-Italy (MAST-I) Group. Randomized controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischemic stroke. Lancet. 1995;346:1509-1514.
47. Multicenter Acute Stroke Trial-Europe Study Group. Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med. 1996;335:145-150.
48. Baron JC, von Kummer R, del Zoppo GJ. Treatment of acute ischemic stroke: challenging the concept of a rigid and universal time window. Stroke. 1995;26:2219-2221.
49. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.